You are here

  • Home
  • Archive
  • Volume 80, Issue 10
  • Correspondence on ‘SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response’

Article metrics

Article menu

This article has a Reply. Please see:

Download PDFPDF
Correspondence
Correspondence on ‘SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response’

 

Online download statistics by month:

Online download statistics by month: July 2021 to November 2023

AbstractFullPdf
Jul 2021627613163
Aug 202147647558
Sep 202141941886
Oct 202134033258
Nov 202118918155
Dec 2021757421
Jan 202214414742
Feb 2022524713
Mar 2022383616
Apr 2022726923
May 2022585925
Jun 2022404218
Jul 2022433811
Aug 2022484816
Sep 2022535319
Oct 2022393916
Nov 2022272616
Dec 2022303013
Jan 2023232213
Feb 202384844
Mar 202314142
Apr 20232411
May 20235931
Jun 20233412
Jul 20236301
Aug 20235350
Sep 20232200
Oct 20233624
Nov 20235062
Total32322865699